MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The monoclonal antibody cytomegalovirus retinitis trial
Douglas A. Jabs
Research output: Contribution to journal › Article › peer-review
46Scopus
citations
Fingerprint
Dive into the research topics of 'MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The monoclonal antibody cytomegalovirus retinitis trial'. Together they form a unique fingerprint.